Millennium Pharmacon International

What Millennium Pharmacon International does

Millennium Pharmacon International appears, based on its name and registered domain (mpi-indonesia.co.id), to be an Indonesia-domiciled entity operating in the pharmaceutical sector — "Pharmacon" derives from the Greek term for a drug or medicine. The.co.id top-level domain indicates an Indonesian commercial registration. Beyond this inferred positioning, no substantive operational data was retrievable: the only accessible web source was a verification/loading page that did not render company content. As a result, the company's specific product lines, therapeutic categories, distribution channels, customer base, regulatory licenses, ownership structure, and revenue mechanics cannot be confirmed from the available evidence.

No information was available on funding rounds, management team, headcount, partnerships, certifications, or geographic footprint. No technology stack, AI capabilities, digital products, or app presence was disclosed. The company's history, founding date, parent/subsidiary relationships, and current operating status are likewise unverified. Any deeper analytical claims about the company's market position, competitive standing, or financial performance would require primary sources that are not present in the input data.

The investment-relevant fact set is therefore minimal: a likely Indonesian pharmaceutical-sector entity with an unverified business profile. Diligence would require direct access to the company website, Indonesian corporate registry filings (e.g., AHU records), BPOM pharmaceutical licensing data, and audited financial statements before any commercial assessment can be made.

Name

Millennium Pharmacon International

Website

https://mpi-indonesia.co.id

Company type

Private

Founded year

1952

Headcount range

1,001–5,000 employees

Short description

Millennium Pharmacon International is an Indonesia-domiciled entity (mpi-indonesia.co.id) whose name indicates pharmaceutical-sector activity, but no substantive operational, product, customer, or financial data was available in the input sources.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

akta.pro secondary industry

Controlled Substances & Compliance-Focused Pharmaceutical Distributors (HLAIAJAN)

Keywords

• Pharmaceutical distribution
• Pharmaceutical products
• Indonesia pharmaceuticals
• Pharma trading
• Medicine supply

Headquarters

HQ city

Jakarta

HQ country

Indonesia

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales

Core offering

Based on the company name ("Millennium Pharmacon International") and the .co.id domain, the company appears to be involved in the pharmaceutical sector in Indonesia — likely distributing or trading pharmaceutical products. No product, service, or operating detail is directly evidenced because the source page only displayed a verification/loading screen.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Tempo Scan Pacific: Indonesian pharmaceutical and consumer healthcare group with manufacturing and nationwide distribution; comparable to Millennium Pharmacon as a local Indonesian pharma distributor with multi-channel reach.
• Kimia Farma: Indonesian state-affiliated pharmaceutical manufacturer and distributor operating the largest pharmacy retail and distribution network in Indonesia; directly comparable as a domestic pharma distributor serving government and private channels.
• Kalbe Farma: Indonesia's largest pharmaceutical company with extensive manufacturing, distribution, and retail pharmacy operations; comparable as a broad-line domestic pharma distributor and one of the most important benchmarks for any Indonesian pharma distributor.
• PT Enseval Putera Megatrading: Major Indonesian pharmaceutical and consumer goods distributor (Kalbe Farma's distribution arm) with nationwide reach; directly comparable as an Indonesian pharma-focused wholesaler.
• Indofarma: Indonesian state-owned pharmaceutical manufacturer and distributor listed on the IDX; comparable in product range, distribution footprint, and exposure to government pharmaceutical tenders in Indonesia.
• PT Anugrah Argon Medica (AAM): One of Indonesia's largest pharmaceutical distributors serving multinational principals; comparable as a dedicated pharma distribution specialist operating across the Indonesian archipelago.
• Pyridam Farma: Indonesian pharmaceutical company producing and distributing generic and branded medicines across the archipelago; directly comparable to Millennium Pharmacon as a domestic Indonesian pharma distributor.
• PT Mensa Bina Sukses: Indonesian pharmaceutical distribution company serving multinational and local principals; comparable to Millennium Pharmacon as a domestic specialty pharma wholesaler.

Regional players

• PT Parit Padang Global (Double Deer / Sime Darby): Indonesia-headquartered pharmaceutical and consumer healthcare distribution group; comparable regional distributor operating in Indonesian pharma wholesale channels.

Broad incumbents

• Sanofi Indonesia: Multinational pharmaceutical manufacturer with significant distribution operations in Indonesia; comparable as an established player in Indonesian pharmaceutical supply chains and channel management.

Market position

Strengths3 records

Weaknesses4 records

Key risks5 records

Key highlights2 records

Customer concentration

• LinkedInlinkedin.com/company/pt-millennium-pharmacon-international-tbk

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Millennium Pharmacon International